Parkinson’s Disease: A Neurodegenerative Disease

Journal Title: Journal of Clinical Medical Research - Year 2022, Vol 3, Issue 2

Abstract

Parkinson’s disease is characterized by tremor, stiffness, rigid muscles, bradykinesia, slowness of movement, instability leading to falls, memory and talking difficulties, fatigue, writing modifications (micrography) and dementia. In addition, depression, urinary (bladder) problems, constipation, decreased ability to smell and sleep disruption are among the symptoms associated to the PD. As Parkinson’s cannot be eradicate, treatments are oriented toward a slow decline and deterioration and therefore, only palliative care predominates. Mutations of 6 genes (SNCA, LRRK2, PRKN, DJ1, PINK1 and ATP13A2), are the cause of familial Parkinsonism. They are playing a role in the metabolism of α-synucleine, in mitochondrial control, oxidative stress, lysosomal functions, transport and recycling of proteins and immunologic activities. Five stages with increased gravity have been identified. From stage 1 to 3, symptoms may be treated with pharmacological drugs. At stages 4 and 5, the patient needs assistive help and an ambulatory walker device. L-dopa is transformed in dopamine in the brain. Treatments for speech disorders increase the disability of these symptoms. Dopamine agonists, MAO-B and COMT inhibitors contribute to help break down dopamine, an anticholinergic drug aiming to reduce tremors and muscle rigidity. Death is occurring within 7 to 15 years.

Authors and Affiliations

Michel Goldberg1*

Keywords

Related Articles

Integrating Artificial Intelligence and Neural Networks for Enhanced Diagnosis of Atopic Dermatitis

Introduction: Atopic dermatitis, a chronic inflammatory skin condition, disproportionately affects young children. Statistics show that up to 90% of cases are diagnosed before the age of five. Despite its prevalence, the...

Optimizing Polycystic Ovarian Disorder (PCOD) Treatment with Personalized Lifestyle and Nutrition Strategies

Introduction: Polycystic Ovarian Disorder (PCOD) is a prevalent endocrine illness in women of reproductive age. It has hormonal abnormalities, irregular menstrual cycles and tiny ovarian cysts. Lifestyle and food affect...

Precision Drugs

The mantra of precision medicine is to prevent and treat diseases by considering individual variability in genes, environment and lifestyle for each person. However, precision drugs to enable precision medicine are not y...

Single Center Retrospective Study of Functional Outcomes after Scapulectomy with Glenohumeral Joint Preservation for No Metastatic Primary Malignant Tumors of the Scapula

Objective: through the present study, we try to evaluate the functional outcomes after scapulectomy with glenohumeral joint preservation for no metastatic primary malignant tumors of the scapula. Material and Methods:...

A Single Center Prospective Observational Cohort Study on the Association of Asia Pacific Classification of Body Mass Index, Waist Circumference, Waist Hip Ratio with COVID-19 Outcomes and Severity in a Philippine Tertiary Hospital

Objective: This study aimed to determine the association between Asia-Pacific classification of body mass index, waist circumference and waist hip ratio and clinical outcomes of COVID-19 moderate & severe patients at the...

Download PDF file
  • EP ID EP704386
  • DOI http://dx.doi.org/10.46889/JCMR.2022.3203
  • Views 91
  • Downloads 0

How To Cite

Michel Goldberg1* (2022). Parkinson’s Disease: A Neurodegenerative Disease. Journal of Clinical Medical Research, 3(2), -. https://www.europub.co.uk/articles/-A-704386